ACRS
#2537
Aclaris Therapeutics, Inc. - Common Stock
5.9 8 USD
-0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.92%
Variación mensual
+11.99%
Variación en los últimos 6 meses
+111.31%
Cambio anual
+223.24%
Cierres anteriores
6.1 6
Open
5.9 8
Mínimo
5.9 5
Máximo
6.0 1
Volumen
272
Financials
- Market Capitalization 880.25 M
- Employee 73
- Founded 2012
- CEO N/A
- Website www.aclaristx.com
- Headquarter Delaware, United States
- FIGI BBG003LF0QR9
- Industry Diagnóstico y pruebas
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-5.68
Relación precio/flujo de caja
47.14
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2400 |  OPK Opko Health, Inc. - Common Stock | 1.48 USD | -1.33% | -1.33% | -10.30% | +4.96% | 1.10 B USD | ||
| 2434 |  CSTL Castle Biosciences, Inc. - Common stock | 32.96 USD | -3.79% | -4.33% | +37.74% | +33.90% | 1.01 B USD | ||
| 2883 |  FLGT Fulgent Genetics, Inc. - Common Stock | 19.64 USD | -1.55% | -1.55% | +0.77% | -16.89% | 540.40 M USD | ||
| 3007 |  PRE Prenetics Global Limited - Class A Ordinary Share | 26.13 USD | -0.46% | +34.55% | +43.18% | +246.55% | 440.92 M USD |